Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2026-01-27 @ 1:50 AM
Study NCT ID:
NCT06523192
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2024-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire
Sponsor:
University Hospitals, Leicester
Organization:
Study Overview
Official Title:
The English Version of the Drug Hypersensitivity Quality of Life Questionnaire: Validity and Reliability in the British Population.
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabelling.
This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London.
Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic.
Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London.
Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic.
Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: